Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear receptor activity	NR5A2 AHR NR4A1 NR3C1	6.16e-05	60	71	4	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	NR5A2 AHR NR4A1 NR3C1	6.57e-05	61	71	4	GO:0098531
GeneOntologyMolecularFunction	transcription coregulator binding	NR5A2 AHR PAX3 BSN RUNX3	1.42e-04	140	71	5	GO:0001221
GeneOntologyBiologicalProcess	cell proliferation in forebrain	IGF2BP1 NFIB NUMB FGFR2	7.77e-06	38	69	4	GO:0021846
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	PWWP2A HOXB3 RPS6KA5 EGR1 NFIB NR5A2 DVL2 AHR PAX3 FGFR2 PAX9 NR4A1 NR3C1 FUBP3 NIPBL LDB2	1.05e-05	1390	69	16	GO:0045944
GeneOntologyBiologicalProcess	animal organ morphogenesis	HOXB3 COL11A2 NFIB INSL4 SEC24B NR5A2 DVL2 AHR NUMB PAX3 FGFR2 PAX9 NR3C1 NIPBL AHDC1	1.54e-05	1269	69	15	GO:0009887
GeneOntologyBiologicalProcess	mammary gland specification	PAX3 FGFR2	6.59e-05	4	69	2	GO:0060594
GeneOntologyBiologicalProcess	mammary gland morphogenesis	INSL4 PAX3 FGFR2 NR3C1	6.66e-05	65	69	4	GO:0060443
GeneOntologyBiologicalProcess	mesenchymal cell proliferation involved in lung development	NFIB FGFR2	1.64e-04	6	69	2	GO:0060916
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	HMBOX1 HOXB3 EGR1 NFIB AHR PAX3 FGFR2 NR3C1 RUNX3 NIPBL LDB2 MXI1	1.75e-04	1053	69	12	GO:0000122
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	HMBOX1 HOXB3 RPS6KA5 EGR1 NFIB AHR PAX3 FGFR2 PAX9 NR3C1 RUNX3 NIPBL LDB2 MXI1	1.85e-04	1399	69	14	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	HMBOX1 HOXB3 RPS6KA5 EGR1 NFIB AHR PAX3 FGFR2 PAX9 NR3C1 RUNX3 NIPBL LDB2 MXI1	2.06e-04	1413	69	14	GO:1902679
GeneOntologyBiologicalProcess	mammary gland development	INSL4 IRS2 PAX3 FGFR2 NR3C1	2.11e-04	162	69	5	GO:0030879
GeneOntologyBiologicalProcess	outflow tract morphogenesis	SEC24B DVL2 FGFR2 NIPBL	2.79e-04	94	69	4	GO:0003151
GeneOntologyBiologicalProcess	melanosome organization	PIKFYVE HPS5 LYST	3.00e-04	39	69	3	GO:0032438
GeneOntologyBiologicalProcess	pigment granule organization	PIKFYVE HPS5 LYST	3.24e-04	40	69	3	GO:0048753
GeneOntologyBiologicalProcess	gland morphogenesis	NFIB INSL4 PAX3 FGFR2 NR3C1	3.25e-04	178	69	5	GO:0022612
GeneOntologyBiologicalProcess	mammary gland formation	PAX3 FGFR2	3.91e-04	9	69	2	GO:0060592
GeneOntologyBiologicalProcess	lung lobe development	SEC24B FGFR2	3.91e-04	9	69	2	GO:0060462
GeneOntologyBiologicalProcess	lung lobe morphogenesis	SEC24B FGFR2	3.91e-04	9	69	2	GO:0060463
GeneOntologyBiologicalProcess	regulation of epithelial cell proliferation involved in lung morphogenesis	NFIB FGFR2	3.91e-04	9	69	2	GO:2000794
GeneOntologyBiologicalProcess	tube formation	NFIB SEC24B DVL2 PAX3 FGFR2	4.08e-04	187	69	5	GO:0035148
MousePheno	lethality during fetal growth through weaning, incomplete penetrance	CPEB2 PIKFYVE HOXB3 IGF2BP1 NFIB FUBP1 VCAN DVL2 AHR FRYL PAX3 FGFR2 PAX9 NR3C1 RUNX3 F5 NIPBL	3.90e-06	1124	61	17	MP:0011112
MousePheno	abnormal branching involved in lung morphogenesis	NFIB FUBP1 FGFR2 NR3C1	1.38e-05	34	61	4	MP:0011024
MousePheno	abnormal prostate gland morphology	EGR1 INSL4 AHR FGFR2 MXI1	1.60e-05	73	61	5	MP:0001158
MousePheno	perinatal lethality	PIKFYVE HOXB3 IGF2BP1 NFIB FUBP1 VCAN SCN2A INSL4 DVL2 PAX3 FGFR2 PAX9 NR3C1 RUNX3 F5 AHDC1	1.86e-05	1130	61	16	MP:0002081
MousePheno	abnormal prostate gland size	EGR1 INSL4 AHR FGFR2	3.24e-05	42	61	4	MP:0004959
MousePheno	abnormal skin pigmentation	FRYL PAX3 FGFR2 HPS5 LYST	3.76e-05	87	61	5	MP:0002095
MousePheno	abnormal pulmonary alveolar system morphology	PIKFYVE NFIB FUBP1 AHR PAX3 FGFR2 NR3C1 LYST	4.09e-05	296	61	8	MP:0010899
MousePheno	abnormal mammary placode morphology	PAX3 FGFR2	5.60e-05	3	61	2	MP:0013721
MousePheno	absent ultimobranchial body	PAX3 PAX9	5.60e-05	3	61	2	MP:0004914
MousePheno	perinatal lethality, incomplete penetrance	PIKFYVE HOXB3 IGF2BP1 NFIB FUBP1 DVL2 PAX3 NR3C1 RUNX3 F5	5.76e-05	503	61	10	MP:0011090
MousePheno	decreased fetal size	IGF2BP1 NFIB FUBP1 VCAN FGFR2 NIPBL AHDC1	5.94e-05	229	61	7	MP:0004200
MousePheno	decreased tail pigmentation	PAX3 HPS5 LYST	6.16e-05	18	61	3	MP:0011277
MousePheno	abnormal prenatal body size	PIKFYVE IGF2BP1 EGR1 NFIB FUBP1 VCAN HGS SEC24B NR5A2 NUMB PAX3 FGFR2 HUWE1 NIPBL AHDC1	6.60e-05	1116	61	15	MP:0010866
MousePheno	abnormal fetal size	IGF2BP1 NFIB FUBP1 VCAN FGFR2 NIPBL AHDC1	7.38e-05	237	61	7	MP:0004198
MousePheno	hypopigmentation	PAX3 FGFR2 HPS5 LYST	8.19e-05	53	61	4	MP:0005408
MousePheno	abnormal dermal layer morphology	EGR1 VCAN FGFR2 LYST BGN	1.06e-04	108	61	5	MP:0001243
MousePheno	fused tracheal cartilage rings	FGFR2 PAX9	1.12e-04	4	61	2	MP:0004552
MousePheno	decreased circulating testosterone level	EGR1 NR5A2 IRS2 NR3C1	1.33e-04	60	61	4	MP:0002780
MousePheno	abnormal skin coloration	IL12RB1 FRYL PAX3 FGFR2 HPS5 LYST	1.38e-04	182	61	6	MP:0011239
MousePheno	abnormal intramembranous bone ossification	FGFR2 RUNX3 NIPBL AHDC1	1.42e-04	61	61	4	MP:0008273
MousePheno	submandibular gland hypoplasia	NFIB FGFR2	1.86e-04	5	61	2	MP:0009522
MousePheno	abnormal ear morphology	COL11A2 SEC24B PAX3 CACHD1 FGFR2 PAX9 BSN HPS5 LYST	1.86e-04	470	61	9	MP:0002102
MousePheno	abnormal pulmonary acinus morphology	NFIB FUBP1 AHR PAX3 FGFR2 NR3C1 LYST	2.27e-04	284	61	7	MP:0010911
MousePheno	limbs/digits/tail phenotype	IGF2BP1 EGR1 VCAN SEC24B CAST DVL2 PAX3 FGFR2 PAX9 RUNX3 HPS5 LYST NIPBL BGN SON	2.52e-04	1258	61	15	MP:0005371
MousePheno	respiratory distress	NFIB SCN2A PAX3 FGFR2 PAX9 NR3C1	2.56e-04	204	61	6	MP:0001954
MousePheno	abnormal ultimobranchial body morphology	PAX3 PAX9	2.78e-04	6	61	2	MP:0003955
MousePheno	abnormal cardiac outflow tract development	VCAN SEC24B DVL2 PAX3 FGFR2	2.91e-04	134	61	5	MP:0006126
MousePheno	abnormal respiratory function	CPEB2 NFIB SCN2A PAX3 FGFR2 PAX9 NR3C1 RUNX3	3.22e-04	399	61	8	MP:0002327
MousePheno	abnormal endolymphatic duct morphology	PAX3 CACHD1 FGFR2	3.26e-04	31	61	3	MP:0006011
MousePheno	abnormal breathing pattern	CPEB2 NFIB SCN2A PAX3 FGFR2 PAX9 NR3C1	3.36e-04	303	61	7	MP:0001951
MousePheno	abnormal lung development	NFIB FUBP1 FGFR2 NR3C1 LYST	3.80e-04	142	61	5	MP:0001176
MousePheno	athyroidism	PAX3 FGFR2	3.88e-04	7	61	2	MP:0004663
MousePheno	abnormal platelet ADP level	HPS5 LYST	3.88e-04	7	61	2	MP:0009556
MousePheno	decreased platelet ADP level	HPS5 LYST	3.88e-04	7	61	2	MP:0009557
MousePheno	abnormal branching involved in terminal bronchiole morphogenesis	NFIB NR3C1	3.88e-04	7	61	2	MP:0011031
MousePheno	absent thyroid gland	PAX3 FGFR2	3.88e-04	7	61	2	MP:0005314
MousePheno	arrest of tooth development	FGFR2 PAX9	3.88e-04	7	61	2	MP:0000118
MousePheno	aberrant origin of the right subclavian artery	SEC24B PAX3 PAX9	3.93e-04	33	61	3	MP:0010465
MousePheno	abnormal somatic nervous system morphology	CPEB2 PIKFYVE HOXB3 EGR1 HGS SEC24B NUMB IRS2 PAX3 CACHD1 FGFR2 BSN RUNX3	3.94e-04	1025	61	13	MP:0002752
MousePheno	abnormal fetal growth/weight/body size	IGF2BP1 NFIB FUBP1 VCAN FGFR2 NIPBL AHDC1	4.01e-04	312	61	7	MP:0004197
MousePheno	abnormal respiratory system morphology	PIKFYVE COL11A2 EGR1 NFIB FUBP1 SEC24B AHR PAX3 FGFR2 PAX9 NR3C1 RUNX3 LYST	4.01e-04	1027	61	13	MP:0002132
MousePheno	abnormal somite development	VCAN HGS DVL2 PAX3 HUWE1 F5	4.02e-04	222	61	6	MP:0001688
MousePheno	abnormal lung morphology	PIKFYVE EGR1 NFIB FUBP1 SEC24B AHR PAX3 FGFR2 NR3C1 RUNX3 LYST	4.25e-04	767	61	11	MP:0001175
MousePheno	cyanosis	NFIB VCAN SCN2A DVL2 PAX3 NR3C1	4.42e-04	226	61	6	MP:0001575
MousePheno	abnormal extraembryonic tissue morphology	PIKFYVE IGF2BP1 FUBP1 VCAN HGS SEC24B NR5A2 NUMB FRYL FGFR2 F5 NIPBL	4.74e-04	908	61	12	MP:0002086
MousePheno	abnormal circulating testosterone level	EGR1 NR5A2 IRS2 NR3C1	4.88e-04	84	61	4	MP:0005180
MousePheno	abnormal circulating androgen level	EGR1 NR5A2 IRS2 NR3C1	4.88e-04	84	61	4	MP:0009819
MousePheno	abnormal blastocoele morphology	PIKFYVE NUP214 FGFR2	5.09e-04	36	61	3	MP:0004963
MousePheno	decreased submandibular gland size	NFIB FGFR2	5.16e-04	8	61	2	MP:0009520
MousePheno	ectopic thymus	PAX3 PAX9	5.16e-04	8	61	2	MP:0003007
MousePheno	abnormal bronchiole morphology	NFIB FGFR2 NR3C1	5.53e-04	37	61	3	MP:0002267
MousePheno	abnormal aortic arch and aortic arch branch attachment	SEC24B PAX3 PAX9	5.53e-04	37	61	3	MP:0010464
MousePheno	neonatal lethality	HOXB3 NFIB FUBP1 VCAN INSL4 PAX3 FGFR2 PAX9 NR3C1 RUNX3 F5	6.00e-04	799	61	11	MP:0002058
MousePheno	abnormal cardiovascular development	VCAN HGS SEC24B DVL2 AHR NUMB A4GNT PAX3 FGFR2 PAX9 AHDC1	6.19e-04	802	61	11	MP:0002925
MousePheno	abnormal tail pigmentation	PAX3 HPS5 LYST	6.46e-04	39	61	3	MP:0005174
MousePheno	abnormal respiratory system development	NFIB FUBP1 FGFR2 NR3C1 LYST	6.55e-04	160	61	5	MP:0003115
MousePheno	abnormal pharyngeal pouch morphology	PAX3 PAX9	6.61e-04	9	61	2	MP:0006031
MousePheno	postnatal lethality	CPEB2 PIKFYVE IGF2BP1 NFIB SCN2A AHR FRYL PAX3 FGFR2 PAX9 NR3C1 RUNX3 NIPBL	6.72e-04	1084	61	13	MP:0002082
MousePheno	abnormal testosterone level	EGR1 NR5A2 IRS2 NR3C1	6.88e-04	92	61	4	MP:0011385
MousePheno	abnormal right subclavian artery morphology	SEC24B PAX3 PAX9	6.96e-04	40	61	3	MP:0010487
MousePheno	abnormal cochlea morphology	COL11A2 SEC24B PAX3 CACHD1 FGFR2 BSN	7.21e-04	248	61	6	MP:0000031
MousePheno	decreased heart atrium size	FGFR2 NIPBL	8.24e-04	10	61	2	MP:0031577
MousePheno	abnormal vestibuloocular reflex	AHR LYST	8.24e-04	10	61	2	MP:0004844
MousePheno	abnormal terminal bronchiole morphology	NFIB NR3C1	8.24e-04	10	61	2	MP:0002268
MousePheno	heart atrium hypoplasia	FGFR2 NIPBL	8.24e-04	10	61	2	MP:0004055
MousePheno	abnormal mammary gland embryonic development	PAX3 FGFR2	8.24e-04	10	61	2	MP:0004135
MousePheno	abnormal platelet ATP level	HPS5 LYST	8.24e-04	10	61	2	MP:0009447
MousePheno	decreased platelet ATP level	HPS5 LYST	8.24e-04	10	61	2	MP:0009448
MousePheno	abnormal oxygen level	NFIB VCAN SCN2A DVL2 PAX3 NR3C1	8.50e-04	256	61	6	MP:0001574
MousePheno	impaired lung alveolus development	FGFR2 NR3C1 LYST	9.22e-04	44	61	3	MP:0006027
MousePheno	ventricular septal defect	VCAN DVL2 PAX3 FGFR2 PAX9 NIPBL	9.40e-04	261	61	6	MP:0010402
MousePheno	perinatal lethality, complete penetrance	NFIB FUBP1 VCAN SCN2A PAX3 FGFR2 PAX9 NR3C1 F5 AHDC1	9.41e-04	712	61	10	MP:0011089
MousePheno	abnormal lung size	NFIB FUBP1 SEC24B FGFR2 NR3C1	9.56e-04	174	61	5	MP:0004881
MousePheno	abnormal membranous labyrinth morphology	COL11A2 SEC24B PAX3 CACHD1 FGFR2 BSN	9.59e-04	262	61	6	MP:0000035
MousePheno	decreased osteoblast cell number	FGFR2 RUNX3 BGN	9.85e-04	45	61	3	MP:0004989
MousePheno	abnormal prostate gland development	INSL4 FGFR2	1.00e-03	11	61	2	MP:0009735
MousePheno	abnormal dorsal root ganglion morphology	PIKFYVE NUMB PAX3 RUNX3	1.09e-03	104	61	4	MP:0000961
MousePheno	abnormal neurocranium morphology	PAX3 CACHD1 FGFR2 PAX9 RUNX3 NIPBL	1.10e-03	269	61	6	MP:0000074
MousePheno	abnormal hindbrain morphology	PIKFYVE NFIB FUBP1 HGS PAX3 FGFR2 LYST NIPBL	1.16e-03	485	61	8	MP:0000841
MousePheno	decreased ear pigmentation	HPS5 LYST	1.20e-03	12	61	2	MP:0011279
MousePheno	abnormal pons morphology	PIKFYVE NFIB HGS	1.26e-03	49	61	3	MP:0000848
MousePheno	abnormal circulating progesterone level	EGR1 NR5A2 IRS2	1.34e-03	50	61	3	MP:0005184
MousePheno	abnormal lung alveolus development	FGFR2 NR3C1 LYST	1.34e-03	50	61	3	MP:0010995
MousePheno	abnormal common carotid artery morphology	PAX3 PAX9	1.42e-03	13	61	2	MP:0012729
MousePheno	abnormal thyroid gland development	PAX3 PAX9	1.42e-03	13	61	2	MP:0003421
MousePheno	abnormal auchene hair morphology	AHR RUNX3	1.42e-03	13	61	2	MP:0000405
MousePheno	decreased spinal cord size	HGS RUNX3	1.42e-03	13	61	2	MP:0000956
MousePheno	abnormal prenatal growth/weight/body size	PIKFYVE IGF2BP1 EGR1 NFIB FUBP1 VCAN HGS SEC24B NR5A2 NUMB PAX3 FGFR2 HUWE1 NIPBL AHDC1	1.53e-03	1493	61	15	MP:0004196
MousePheno	abnormal placenta labyrinth morphology	FUBP1 NUMB FRYL FGFR2 NIPBL	1.55e-03	194	61	5	MP:0001716
MousePheno	small lung	NFIB FUBP1 SEC24B FGFR2	1.58e-03	115	61	4	MP:0003641
MousePheno	abnormal trabecular bone morphology	EGR1 HGS FGFR2 RUNX3 BGN SON	1.59e-03	289	61	6	MP:0000130
MousePheno	abnormal choroid pigmentation	HPS5 LYST	1.65e-03	14	61	2	MP:0005100
MousePheno	decreased molar number	FGFR2 PAX9	1.65e-03	14	61	2	MP:0006400
MousePheno	premature intramembranous bone ossification	FGFR2 AHDC1	1.65e-03	14	61	2	MP:0003418
MousePheno	thin placenta labyrinth	FUBP1 NUMB	1.65e-03	14	61	2	MP:0011523
MousePheno	premature cranial suture closure	FGFR2 AHDC1	1.65e-03	14	61	2	MP:0000081
MousePheno	premature craniofacial suture closure	FGFR2 AHDC1	1.65e-03	14	61	2	MP:0030435
MousePheno	abnormal Langerhans cell morphology	AHR RUNX3	1.65e-03	14	61	2	MP:0008117
MousePheno	hearing/vestibular/ear phenotype	COL11A2 SEC24B AHR PAX3 CACHD1 FGFR2 PAX9 BSN HPS5 LYST NIPBL	1.66e-03	905	61	11	MP:0005377
MousePheno	pulmonary hypoplasia	NFIB FUBP1 FGFR2	1.67e-03	54	61	3	MP:0001178
Domain	KH_1	IGF2BP1 FUBP1 FUBP3 HDLBP	1.43e-05	38	73	4	PF00013
Domain	-	IGF2BP1 FUBP1 FUBP3 HDLBP	1.59e-05	39	73	4	3.30.1370.10
Domain	KH	IGF2BP1 FUBP1 FUBP3 HDLBP	1.76e-05	40	73	4	SM00322
Domain	KH_dom	IGF2BP1 FUBP1 FUBP3 HDLBP	1.76e-05	40	73	4	IPR004087
Domain	KH_TYPE_1	IGF2BP1 FUBP1 FUBP3 HDLBP	2.15e-05	42	73	4	PS50084
Domain	KH_dom_type_1	IGF2BP1 FUBP1 FUBP3 HDLBP	2.59e-05	44	73	4	IPR004088
Domain	PAX	PAX3 PAX9	5.33e-04	9	73	2	SM00351
Domain	Paired_dom	PAX3 PAX9	5.33e-04	9	73	2	IPR001523
Domain	PAIRED_2	PAX3 PAX9	5.33e-04	9	73	2	PS51057
Domain	PAX	PAX3 PAX9	5.33e-04	9	73	2	PF00292
Domain	PAIRED_1	PAX3 PAX9	5.33e-04	9	73	2	PS00034
Domain	zf-C4	NR5A2 NR4A1 NR3C1	7.71e-04	46	73	3	PF00105
Domain	Znf_hrmn_rcpt	NR5A2 NR4A1 NR3C1	7.71e-04	46	73	3	IPR001628
Domain	Nuclear_hrmn_rcpt	NR5A2 NR4A1 NR3C1	7.71e-04	46	73	3	IPR001723
Domain	NUCLEAR_REC_DBD_2	NR5A2 NR4A1 NR3C1	7.71e-04	46	73	3	PS51030
Domain	NUCLEAR_REC_DBD_1	NR5A2 NR4A1 NR3C1	7.71e-04	46	73	3	PS00031
Domain	ZnF_C4	NR5A2 NR4A1 NR3C1	7.71e-04	46	73	3	SM00399
Domain	-	NR5A2 NR4A1 NR3C1	8.21e-04	47	73	3	1.10.565.10
Domain	HOLI	NR5A2 NR4A1 NR3C1	8.73e-04	48	73	3	SM00430
Domain	Nucl_hrmn_rcpt_lig-bd	NR5A2 NR4A1 NR3C1	8.73e-04	48	73	3	IPR000536
Domain	Hormone_recep	NR5A2 NR4A1 NR3C1	8.73e-04	48	73	3	PF00104
Domain	-	NR5A2 NR4A1 NR3C1	1.44e-03	57	73	3	3.30.50.10
Domain	Znf_NHR/GATA	NR5A2 NR4A1 NR3C1	1.52e-03	58	73	3	IPR013088
Domain	DS_RBD	ADARB2 SON	3.02e-03	21	73	2	PS50137
Domain	DEP	PIKFYVE DVL2	3.31e-03	22	73	2	PF00610
Domain	DEP	PIKFYVE DVL2	3.31e-03	22	73	2	PS50186
Domain	DEP	PIKFYVE DVL2	3.31e-03	22	73	2	SM00049
Domain	G_patch	ERVK-6 SON	3.61e-03	23	73	2	SM00443
Domain	G_patch_dom	ERVK-6 SON	3.61e-03	23	73	2	IPR000467
Domain	DEP_dom	PIKFYVE DVL2	3.61e-03	23	73	2	IPR000591
Domain	G_PATCH	ERVK-6 SON	3.61e-03	23	73	2	PS50174
Domain	G-patch	ERVK-6 SON	3.61e-03	23	73	2	PF01585
Domain	UIM	HGS HUWE1	3.93e-03	24	73	2	PS50330
Domain	UIM_dom	HGS HUWE1	4.26e-03	25	73	2	IPR003903
Domain	-	ADARB2 SON	4.96e-03	27	73	2	3.30.160.20
Domain	PID	MAPK8IP1 NUMB	5.33e-03	28	73	2	PF00640
Domain	dsRBD_dom	ADARB2 SON	5.33e-03	28	73	2	IPR014720
Domain	FYVE	PIKFYVE HGS	5.71e-03	29	73	2	PF01363
Domain	FYVE	PIKFYVE HGS	5.71e-03	29	73	2	SM00064
Domain	PH_dom-like	MAPK8IP1 PSD3 NUMB IRS2 ARHGEF11 LYST	6.39e-03	426	73	6	IPR011993
Domain	PID	MAPK8IP1 NUMB	6.93e-03	32	73	2	PS01179
Domain	Znf_FYVE-rel	PIKFYVE HGS	7.80e-03	34	73	2	IPR017455
Pathway	WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING	RPS6KA5 EGR1 NR3C1	5.21e-05	19	55	3	M39358
Pathway	WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING	IGF2BP1 RPS6KA5 EGR1 PRKAA2 IRS2	2.39e-04	144	55	5	M39691
Pathway	WP_VEGFAVEGFR2_SIGNALING	KANK1 RPS6KA5 EGR1 HGS PRKAA2 NUMB NR4A1 LDB2	2.47e-04	431	55	8	M39729
Pathway	WP_INSULIN_SIGNALING	RPS6KA5 EGR1 PIK3C2G PRKAA2 IRS2	3.89e-04	160	55	5	M39482
Pathway	REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE	VCAN BGN	4.12e-04	8	55	2	M27260
Pathway	REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS	VCAN BGN	4.12e-04	8	55	2	M27261
Pathway	REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD	VCAN BGN	4.12e-04	8	55	2	M27259
Pathway	WP_NUCLEAR_RECEPTORS	NR5A2 NR4A1 NR3C1	4.30e-04	38	55	3	M39657
Pathway	WP_NUCLEAR_RECEPTORS	NR5A2 NR4A1 NR3C1	4.30e-04	38	55	3	MM15865
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	COL11A2 DVL2 PAX3 FGFR2	5.49e-04	97	55	4	MM15926
Pathway	WP_NEURAL_CREST_DIFFERENTIATION	COL11A2 DVL2 PAX3 FGFR2	6.40e-04	101	55	4	M39448
Pathway	REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS	VCAN BGN	6.59e-04	10	55	2	MM14801
Pathway	BIOCARTA_NPC_PATHWAY	NUP214 NUP153	8.04e-04	11	55	2	M22033
Pathway	REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS	VCAN BGN	8.04e-04	11	55	2	M27105
Pathway	WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING	RPS6KA5 EGR1 PRKAA2 NR4A1	8.23e-04	108	55	4	M48078
Pathway	WP_SPINAL_CORD_INJURY	LILRA1 EGR1 VCAN NR4A1	8.23e-04	108	55	4	MM15954
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR5A2 NR4A1 NR3C1	8.58e-04	48	55	3	MM14987
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HGS SEC24B DVL2 PSD3 NUMB IRS2 NUP214 CACHD1 THSD1 NUP153 HDLBP	2.61e-07	708	73	11	39231216
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	HMBOX1 PIKFYVE GTF3C1 ZNF185 NR5A2 AHR PAX3 PAX9 NR4A1 NR3C1 LDB2	2.64e-07	709	73	11	22988430
Pubmed	Fibroblast Growth Factor 2 Modulates Hypothalamic Pituitary Axis Activity and Anxiety Behavior Through Glucocorticoid Receptors.	EGR1 FGFR2 NR3C1	3.09e-07	7	73	3	27133954
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	IGF2BP1 SEC24B CAST DVL2 NUMB IRS2 NUP214 NR3C1 NIPBL NUP153 SON HDLBP	5.36e-07	934	73	12	33916271
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	GTF3C1 RPS6KA5 FUBP1 CAST IRS2 NUP214 HUWE1 NIPBL NUP153 SON HDLBP	6.27e-07	774	73	11	15302935
Pubmed	Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta.	NUP214 NR3C1 NUP153	1.05e-06	10	73	3	19581287
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	IGF2BP1 GTF3C1 FUBP1 NUMB IRS2 HUWE1 NIPBL NUP153 SON	1.10e-06	503	73	9	16964243
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	BSN AHDC1 NUP153	1.93e-06	12	73	3	28700933
Pubmed	Pax3 and Pax7 play essential safeguard functions against environmental stress-induced birth defects.	AHR PAX3 PAX9	1.93e-06	12	73	3	25800090
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	HMBOX1 EGR1 NFIB NR5A2 PAX3 PAX9 NR4A1 NR3C1 RUNX3	2.09e-06	544	73	9	28473536
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	GTF3C1 EGR1 NR5A2 AHR PAX3 PAX9 NR3C1 RUNX3 FUBP3 LDB2 MXI1	2.11e-06	877	73	11	20211142
Pubmed	A census of human transcription factors: function, expression and evolution.	HMBOX1 HOXB3 EGR1 NFIB NR5A2 PAX3 PAX9 NR4A1 NR3C1 RUNX3 MXI1	2.94e-06	908	73	11	19274049
Pubmed	Expression of glucocorticoid receptor and early growth response gene 1 during postnatal development of two inbred strains of mice exposed to early life stress.	EGR1 NR3C1	4.35e-06	2	73	2	20453467
Pubmed	Adipocyte-Derived Versican and Macrophage-Derived Biglycan Control Adipose Tissue Inflammation in Obesity.	VCAN BGN	4.35e-06	2	73	2	32610121
Pubmed	A transcription factor-based mechanism for mouse heterochromatin formation.	PAX3 PAX9	4.35e-06	2	73	2	22983563
Pubmed	An evidence for regulatory cross-talk between aryl hydrocarbon receptor and glucocorticoid receptor in HepG2 cells.	AHR NR3C1	4.35e-06	2	73	2	17552871
Pubmed	Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia.	EGR1 LDB2	4.35e-06	2	73	2	33656268
Pubmed	The nuclear receptor nr4a1 controls CD8 T cell development through transcriptional suppression of runx3.	NR4A1 RUNX3	4.35e-06	2	73	2	25762306
Pubmed	Hrs regulates the endocytic sorting of the fibroblast growth factor receptor 2b.	HGS FGFR2	4.35e-06	2	73	2	19362549
Pubmed	Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study.	VCAN BGN	4.35e-06	2	73	2	33649986
Pubmed	Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile.	MALL RUNX3	4.35e-06	2	73	2	33672337
Pubmed	The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids.	EGR1 NR3C1	4.35e-06	2	73	2	15834420
Pubmed	Quantitative trait loci for body weight in the intercross between SM/J and A/J mice.	EGR1 NR3C1	4.35e-06	2	73	2	11515095
Pubmed	Crosstalk between activated forms of the aryl hydrocarbon receptor and glucocorticoid receptor.	AHR NR3C1	4.35e-06	2	73	2	19463884
Pubmed	Kindling and associated mossy fibre sprouting are not affected in mice deficient of NGFI-A/NGFI-B genes.	EGR1 NR4A1	4.35e-06	2	73	2	9466414
Pubmed	Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition.	RPS6KA5 NR3C1	4.35e-06	2	73	2	18511904
Pubmed	Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.	COL11A2 AHR PAX3 FGFR2 PAX9 NR3C1 NIPBL	6.31e-06	331	73	7	20634891
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	CPEB2 IGF2BP1 FUBP1 ADARB2 FUBP3 SON HDLBP	8.58e-06	347	73	7	16033648
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	GTF3C1 FRYL NUP214 HUWE1 FUBP3 NIPBL NUP153 SON HDLBP	9.14e-06	653	73	9	22586326
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	IGF2BP1 GTF3C1 FUBP1 NUP214 HUWE1 F5 FUBP3 NIPBL NUP153 SON HDLBP	9.17e-06	1024	73	11	24711643
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	PDPR HGS SEC24B PSD3 NUMB CACHD1 HID1 HUWE1 PTPRU NUP153 HDLBP	1.15e-05	1049	73	11	27880917
Pubmed	Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.	HGS HUWE1 NUP153 HDLBP	1.24e-05	67	73	4	29357390
Pubmed	The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer.	FUBP1 FUBP3	1.30e-05	3	73	2	19087307
Pubmed	Profiling of enantiopure drugs towards aryl hydrocarbon (AhR), glucocorticoid (GR) and pregnane X (PXR) receptors in human reporter cell lines.	AHR NR3C1	1.30e-05	3	73	2	24316275
Pubmed	Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves.	VCAN BGN	1.30e-05	3	73	2	18621549
Pubmed	NOT, a human immediate-early response gene closely related to the steroid/thyroid hormone receptor NAK1/TR3.	NR4A1 NR3C1	1.30e-05	3	73	2	7877627
Pubmed	A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor.	AHR NR3C1	1.30e-05	3	73	2	8139547
Pubmed	Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines.	EGR1 NR4A1	1.30e-05	3	73	2	7768965
Pubmed	The methylated-DNA binding protein MBD2 enhances NGFI-A (egr-1)-mediated transcriptional activation of the glucocorticoid receptor.	EGR1 NR3C1	1.30e-05	3	73	2	25135974
Pubmed	Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.	NR4A1 NR3C1	1.30e-05	3	73	2	15591535
Pubmed	PAX3 Confers Functional Heterogeneity in Skeletal Muscle Stem Cell Responses to Environmental Stress.	AHR PAX3	1.30e-05	3	73	2	31006622
Pubmed	Nucleoporins nup98 and nup214 participate in nuclear export of human immunodeficiency virus type 1 Rev.	NUP214 NUP153	1.30e-05	3	73	2	9847314
Pubmed	Serum amyloid A-containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties.	VCAN BGN	1.30e-05	3	73	2	32970631
Pubmed	The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells.	EGR1 NR4A1	1.30e-05	3	73	2	9858508
Pubmed	Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus.	NUP214 NUP153	1.30e-05	3	73	2	12191473
Pubmed	Differential proteoglycan and hyaluronan distribution in calcified aortic valves.	VCAN BGN	1.30e-05	3	73	2	21185747
Pubmed	The far upstream element-binding proteins comprise an ancient family of single-strand DNA-binding transactivators.	FUBP1 FUBP3	1.30e-05	3	73	2	8940189
Pubmed	Pre-eclampsia-associated alterations in decorin, biglycan and versican of the umbilical cord vein wall.	VCAN BGN	1.30e-05	3	73	2	17097211
Pubmed	Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver.	IRS2 NR3C1	1.30e-05	3	73	2	30532187
Pubmed	Activated glucocorticoid receptor interacts with the INHAT component Set/TAF-Ibeta and releases it from a glucocorticoid-responsive gene promoter, relieving repression: implications for the pathogenesis of glucocorticoid resistance in acute undifferentiated leukemia with Set-Can translocation.	NUP214 NR3C1	1.30e-05	3	73	2	18096310
Pubmed	Cloning and subcellular localization of a human phosphatidylinositol 3-phosphate 5-kinase, PIKfyve/Fab1.	PIKFYVE HGS	1.30e-05	3	73	2	16448788
Pubmed	The nuclear pore complex: a new dynamic in HIV-1 replication.	NUP214 NUP153	1.30e-05	3	73	2	21327100
Pubmed	Mutational definition of functional domains within the Rev homolog encoded by human endogenous retrovirus K.	ERVK-6 NUP214	1.30e-05	3	73	2	11000203
Pubmed	Nuclear receptors in Leydig cell gene expression and function.	NR5A2 NR4A1 NR3C1	1.33e-05	22	73	3	20375256
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HMBOX1 PWWP2A GTF3C1 NFIB NUP214 NR4A1 FUBP3 NIPBL AHDC1 NUP153 MXI1 SON	1.51e-05	1294	73	12	30804502
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	HGS SEC24B DVL2 NUMB FUBP3 NUP153	1.97e-05	263	73	6	34702444
Pubmed	Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.	HMBOX1 HOXB3 NR5A2 PAX3 NR4A1 NR3C1	1.97e-05	263	73	6	20932939
Pubmed	Huwe1-mediated ubiquitylation of dishevelled defines a negative feedback loop in the Wnt signaling pathway.	DVL2 HUWE1	2.60e-05	4	73	2	24643799
Pubmed	PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.	EGR1 PAX3	2.60e-05	4	73	2	17986608
Pubmed	Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2.	DVL2 IRS2	2.60e-05	4	73	2	24616100
Pubmed	The Ah receptor recruits IKKα to its target binding motifs to phosphorylate serine-10 in histone H3 required for transcriptional activation.	RPS6KA5 AHR	2.60e-05	4	73	2	24519526
Pubmed	Lysyl oxidase (Lox) maps between Grl-1 and Adrb-2 on mouse chromosome 18.	EGR1 NR3C1	2.60e-05	4	73	2	8094989
Pubmed	Planar cell polarity links axes of spatial dynamics in neural-tube closure.	DVL2 ARHGEF11	2.60e-05	4	73	2	22632972
Pubmed	AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK.	PRKAA2 NR3C1	2.60e-05	4	73	2	20660302
Pubmed	An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.	ERVK-6 NUP214	2.60e-05	4	73	2	10557333
Pubmed	Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells.	EGR1 AHR	2.60e-05	4	73	2	18515748
Pubmed	Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes.	VCAN BGN	2.60e-05	4	73	2	9848887
Pubmed	The IGF system in in-vitro human decidualization.	IGF2BP1 IRS2	2.60e-05	4	73	2	19038974
Pubmed	RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone.	AHR NR3C1	2.60e-05	4	73	2	10048155
Pubmed	Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy.	PRKAA2 PAX3	2.60e-05	4	73	2	23983188
Pubmed	Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations.	PAX3 PAX9	2.60e-05	4	73	2	19142206
Pubmed	Merkel Cell-Driven BDNF Signaling Specifies SAI Neuron Molecular and Electrophysiological Phenotypes.	EGR1 NR4A1 RUNX3	2.80e-05	28	73	3	27076431
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	HMBOX1 GTF3C1 NFIB HGS PAX3 HUWE1 RUNX3 SON	3.07e-05	583	73	8	29844126
Pubmed	Axial skeleton anterior-posterior patterning is regulated through feedback regulation between Meis transcription factors and retinoic acid.	HOXB3 PAX3 PAX9	3.12e-05	29	73	3	33298461
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	DVL2 FGFR2 NIPBL HDLBP	3.33e-05	86	73	4	37253089
Pubmed	Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression.	IGF2BP1 FUBP1 FRYL IRS2 PRRC1	3.38e-05	174	73	5	29669786
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	EGR1 NUMB NUP214 BSN PRRC1 NUP153 SON	3.39e-05	430	73	7	35044719
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	NFIB NUMB ARHGEF11 FUBP3 NUP153	3.97e-05	180	73	5	35198878
Pubmed	Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import.	NUP214 NUP153	4.33e-05	5	73	2	12917407
Pubmed	The N-terminal domain of the mammalian nucleoporin p62 interacts with other nucleoporins of the FXFG family during interphase.	NUP214 NUP153	4.33e-05	5	73	2	16730000
Pubmed	Steady-state nuclear localization of exportin-t involves RanGTP binding and two distinct nuclear pore complex interaction domains.	NUP214 NUP153	4.33e-05	5	73	2	12138183
Pubmed	Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins.	NUP214 NUP153	4.33e-05	5	73	2	11777942
Pubmed	A giant nucleopore protein that binds Ran/TC4.	NUP214 NUP153	4.33e-05	5	73	2	7603572
Pubmed	In vivo dissection of a clustered-CTCF domain boundary reveals developmental principles of regulatory insulation.	PAX3 FGFR2	4.33e-05	5	73	2	35817979
Pubmed	Analysis of atherosclerosis susceptibility in mice with genetic defects in platelet function.	HPS5 LYST	4.33e-05	5	73	2	2369371
Pubmed	The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development.	VCAN NR3C1	4.33e-05	5	73	2	12495930
Pubmed	Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse.	EGR1 NR3C1	4.33e-05	5	73	2	8094372
Pubmed	Genomic analysis of mouse retinal development.	EGR1 PIK3C2G PLK5 HGS DVL2 PSD3 FRYL FGFR2 BSN LDB2	4.68e-05	1006	73	10	15226823
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	CPEB2 NFIB FUBP1 NUP214 FUBP3 AHDC1 NUP153	4.99e-05	457	73	7	32344865
Pubmed	Nuclear pore composition regulates neural stem/progenitor cell differentiation in the mouse embryo.	PAX3 NUP214 NUP153	5.07e-05	34	73	3	18539113
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	HMBOX1 IGF2BP1 NUP214 FUBP3	6.25e-05	101	73	4	26949739
Pubmed	Tumor promoter-inducible genes are differentially expressed in the developing mouse.	EGR1 NR4A1	6.48e-05	6	73	2	3185562
Pubmed	Differential expression of glycosaminoglycans and proteoglycans in the migratory pathway of the primordial germ cells of the mouse.	VCAN BGN	6.48e-05	6	73	2	12122449
Pubmed	Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch).	VCAN PAX3	6.48e-05	6	73	2	9486530
Pubmed	Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes.	PAX3 FGFR2	6.48e-05	6	73	2	16720875
Pubmed	Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development.	PAX3 PAX9	6.48e-05	6	73	2	10364424
Pubmed	Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.	NR5A2 AHR	6.48e-05	6	73	2	15798202
Pubmed	Loss of Dact1 disrupts planar cell polarity signaling by altering dishevelled activity and leads to posterior malformation in mice.	DVL2 PAX3	6.48e-05	6	73	2	20145239
Pubmed	Digital quantification of human eye color highlights genetic association of three new loci.	HGS LYST	6.48e-05	6	73	2	20463881
Pubmed	Deletion of Pax1 scoliosis-associated regulatory elements leads to a female-biased tail abnormality.	COL11A2 PAX9	6.48e-05	6	73	2	38461417
Interaction	CTNNB1 interactions	HMBOX1 IGF2BP1 EGR1 SEC24B NR5A2 DVL2 USP43 AHR NUMB PAX3 NUP214 HUWE1 NR4A1 NR3C1 PTPRU HDLBP	4.04e-07	1009	72	16	int:CTNNB1
Interaction	KHSRP interactions	IGF2BP1 FUBP1 SEC24B HUWE1 NR4A1 FUBP3 NIPBL HDLBP	1.39e-05	308	72	8	int:KHSRP
Interaction	FMR1 interactions	HMBOX1 IGF2BP1 FUBP1 DVL2 NR3C1 BSN FUBP3 NIPBL LDB2 HDLBP	1.99e-05	536	72	10	int:FMR1
Interaction	EP300 interactions	HOXB3 IGF2BP1 GTF3C1 RPS6KA5 EGR1 SEC24B DVL2 AHR PAX9 NR4A1 NR3C1 BSN RUNX3 FUBP3 LDB2 SON	2.73e-05	1401	72	16	int:EP300
Interaction	DCAF7 interactions	IGF2BP1 RPS6KA5 SEC24B PRKAA2 NUMB PAX9 NIPBL HDLBP	4.95e-05	368	72	8	int:DCAF7
Interaction	KCNA3 interactions	HGS SEC24B DVL2 PSD3 NUMB IRS2 NUP214 CACHD1 THSD1 BSN NUP153 HDLBP	5.54e-05	871	72	12	int:KCNA3
Interaction	TLE3 interactions	EGR1 NFIB NR5A2 PAX9 NR3C1 NIPBL AHDC1 SON	5.76e-05	376	72	8	int:TLE3
GeneFamily	Paired boxes	PAX3 PAX9	2.25e-04	9	46	2	675
GeneFamily	Nuclear hormone receptors	NR5A2 NR4A1 NR3C1	2.62e-04	49	46	3	71
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	PIKFYVE HGS	2.81e-03	31	46	2	81
GeneFamily	Nucleoporins	NUP214 NUP153	2.99e-03	32	46	2	1051
Coexpression	BUSSLINGER_GASTRIC_NECK_CELLS	COL11A2 EGR1 PIK3C2G A4GNT NR4A1 HDLBP	6.34e-10	36	72	6	M40008
Coexpression	GSE29618_MONOCYTE_VS_PDC_UP	LILRA1 EGR1 CAST IRS2 NUP214 F5 LYST	1.27e-06	199	72	7	M4945
Coexpression	GSE22886_DC_VS_MONOCYTE_DN	LILRA1 RPS6KA5 VCAN IRS2 NUP214 F5 LYST	1.31e-06	200	72	7	M4472
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PIKFYVE KANK1 PSD3 AHR FRYL FGFR2 AHDC1 NUP153	1.70e-06	300	72	8	M8702
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	PIKFYVE NFIB FUBP1 SEC24B PSD3 NUMB FRYL NR3C1 NIPBL AHDC1 NUP153 SON	3.46e-06	856	72	12	M4500
Coexpression	GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP	CPEB2 EGR1 DNAJA4 FRYL NR4A1 SON	7.47e-06	170	72	6	M6697
Coexpression	GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN	EGR1 VCAN CAST FGFR2 ARHGEF11 F5	7.47e-06	170	72	6	M5649
Coexpression	GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN	MAPK8IP1 RPS6KA5 IRS2 NR4A1 NR3C1 MAPKBP1	1.07e-05	181	72	6	M8889
Coexpression	NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	MAPK8IP1 NFIB PSD3 PAX3 FGFR2 LYST KIAA1614	1.64e-05	294	72	7	M41112
Coexpression	IKEDA_MIR30_TARGETS_UP	CPEB2 NFIB CAST IRS2 SON	1.72e-05	116	72	5	M2379
Coexpression	IKEDA_MIR30_TARGETS_UP	CPEB2 NFIB CAST IRS2 SON	1.79e-05	117	72	5	MM931
Coexpression	BROWNE_HCMV_INFECTION_10HR_DN	AHR NR3C1 NIPBL SON	1.85e-05	57	72	4	M8416
Coexpression	GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN	CPEB2 COL11A2 EGR1 AHR IRS2 LYST	1.88e-05	200	72	6	M9668
Coexpression	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	EGR1 VCAN ZNF185 CAST F5 MXI1	1.88e-05	200	72	6	M4966
Coexpression	GRUETZMANN_PANCREATIC_CANCER_DN	KANK1 GTF3C1 NFIB NR5A2 MXI1 HDLBP	1.88e-05	200	72	6	M10431
Coexpression	BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS	EGR1 PIK3C2G NFIB HDLBP	2.27e-05	60	72	4	M40007
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PIKFYVE NFIB FUBP1 SEC24B NUMB FRYL NR3C1 NUP153	4.16e-05	466	72	8	M13522
Coexpression	RUTELLA_RESPONSE_TO_HGF_DN	EGR1 VCAN ZNF185 NUP214 RUNX3 SON	5.22e-05	240	72	6	M6413
Coexpression	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	COL11A2 NUMB MXI1	7.65e-05	30	72	3	MM1154
Coexpression	HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN	LILRA1 EGR1 VCAN IRS2 NR4A1 ARHGEF11	7.79e-05	258	72	6	M41144
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	HMBOX1 RPS6KA5 SEC24B AHR NUMB IRS2 LYST NIPBL PRRC1 MXI1	8.05e-05	822	72	10	M6782
Coexpression	NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	COL11A2 NUMB MXI1	8.45e-05	31	72	3	M1452
Coexpression	LU_AGING_BRAIN_UP	KANK1 VCAN CAST FRYL FGFR2 NIPBL	8.65e-05	263	72	6	M5547
Coexpression	TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL	VCAN CAST AHR NUMB IRS2 NUP214	9.99e-05	270	72	6	M41699
Coexpression	DESCARTES_ORGANOGENESIS_ENDOTHELIAL_CELLS	MALL USP43 NUMB NR4A1 THSD1 LDB2	1.04e-04	272	72	6	MM3634
Coexpression	CUI_TCF21_TARGETS_2_DN	CPEB2 KANK1 RPS6KA5 ZNF185 CAST PSD3 FRYL LYST LDB2 SON	1.10e-04	854	72	10	M1533
Coexpression	FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP	NFIB VCAN USP43 AHR	1.12e-04	90	72	4	M48360
Coexpression	CUI_TCF21_TARGETS_2_DN	CPEB2 KANK1 RPS6KA5 ZNF185 CAST PSD3 FRYL LYST LDB2 SON	1.52e-04	888	72	10	MM1018
Coexpression	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	RPS6KA5 MALL VCAN AHR MXI1	1.54e-04	184	72	5	M3804
Coexpression	DORN_ADENOVIRUS_INFECTION_32HR_DN	FUBP1 NR4A1 FUBP3	1.56e-04	38	72	3	M15590
Coexpression	TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	DNAJA4 NFIB PAX9 ADARB2	1.81e-04	102	72	4	M14455
Coexpression	P53_DN.V1_DN	KANK1 VCAN NR4A1 RUNX3 LYST	1.97e-04	194	72	5	M2697
Coexpression	DORN_ADENOVIRUS_INFECTION_24HR_DN	FUBP1 NR4A1 FUBP3	2.11e-04	42	72	3	M8825
Coexpression	AMIT_EGF_RESPONSE_40_HELA	EGR1 NFIB NR4A1	2.11e-04	42	72	3	M4204
Coexpression	GSE360_CTRL_VS_L_MAJOR_DC_DN	NFIB AHR FRYL IRS2 PAX3	2.22e-04	199	72	5	M5146
Coexpression	GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN	EGR1 CAST PTPRU NUP153 TREML2	2.22e-04	199	72	5	M7976
Coexpression	GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP	COL11A2 VCAN HID1 NR3C1 RUNX3	2.22e-04	199	72	5	M9255
Coexpression	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP	IL12RB1 HOXB3 COL11A2 NFIB NR4A1	2.27e-04	200	72	5	M6307
Coexpression	HALLMARK_HYPOXIA	IRS2 NR3C1 BGN MXI1 HDLBP	2.27e-04	200	72	5	M5891
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP	HOXB3 SEC24B NUMB FRYL SON	2.27e-04	200	72	5	M4033
Coexpression	GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN	CPEB2 IGF2BP1 EGR1 NR4A1 BGN	2.27e-04	200	72	5	M9616
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_DN	IL12RB1 VCAN RUNX3 LYST TREML2	2.27e-04	200	72	5	M3424
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP	EGR1 VCAN CAST NR4A1 RUNX3	2.27e-04	200	72	5	M9895
Coexpression	GSE29618_MONOCYTE_VS_MDC_UP	EGR1 VCAN IRS2 F5 MXI1	2.27e-04	200	72	5	M4948
Coexpression	GSE42724_NAIVE_VS_MEMORY_BCELL_DN	HMBOX1 VCAN SEC24B MAPKBP1 NUP153	2.27e-04	200	72	5	M9793
Coexpression	CUI_DEVELOPING_HEART_C5_VALVAR_CELL	EGR1 VCAN AHR NR4A1 BGN	2.55e-04	205	72	5	M39302
Coexpression	HEVNER_CORTEX_COMMITTED_TO_SUBCEREBRAL_PROJECTION_NEURON_FATE	SCN2A LDB2	2.65e-04	9	72	2	MM429
Coexpression	GOZGIT_ESR1_TARGETS_DN	CPEB2 HOXB3 KANK1 DNAJA4 NR5A2 PSD3 AHR HID1 FGFR2	2.95e-04	786	72	9	M10961
Coexpression	MIKKELSEN_MEF_ICP_WITH_H3K27ME3	HOXB3 MALL PRR19 INSL4 NR5A2	3.75e-04	223	72	5	MM838
Coexpression	PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	HMBOX1 EGR1 VCAN PSD3 NR3C1	3.83e-04	224	72	5	M2500
Coexpression	THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	GTF3C1 RPS6KA5 ZNF185 NUP214 NUP153	4.07e-04	227	72	5	M11234
Coexpression	SESTO_RESPONSE_TO_UV_C2	KANK1 ZNF185 NR3C1	4.46e-04	54	72	3	M2589
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	IGF2BP1 RPS6KA5 EGR1 NFIB VCAN SCN2A PSD3 NUMB ZC3H12B CACHD1 FGFR2 NR4A1 MXI1	1.70e-06	783	71	13	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	EGR1 NFIB VCAN SCN2A PSD3 NR4A1 LDB2 BGN	2.86e-06	265	71	8	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	IGF2BP1 RPS6KA5 EGR1 NFIB VCAN SCN2A PSD3 ZC3H12B CACHD1 NR4A1 LDB2 BGN	1.82e-05	831	71	12	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500	EGR1 VCAN PSD3 NR4A1 BGN	5.54e-05	122	71	5	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	EGR1 NFIB VCAN ZNF185 PSD3 NUMB ZC3H12B CACHD1 FGFR2 NR4A1 BGN	6.37e-05	797	71	11	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000	IGF2BP1 NFIB VCAN NR5A2 NUP214 HUWE1 NR3C1 THSD1 PRRC1 SON HDLBP	7.44e-05	811	71	11	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	MAPK8IP1 IGF2BP1 GTF3C1 SEC24B DVL2 NUMB PAX3 FGFR2 AHDC1 SON HDLBP	1.05e-04	843	71	11	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	EGR1 NFIB VCAN SCN2A PSD3 NUMB FGFR2 NR4A1 LDB2 BGN	1.68e-04	740	71	10	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	EGR1 NFIB VCAN SCN2A PSD3 ZC3H12B BGN	1.80e-04	354	71	7	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_100	EGR1 NR4A1	2.29e-04	7	71	2	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	CPEB2 RPS6KA5 NFIB VCAN SCN2A AHR HUWE1 NR3C1 ADARB2 HDLBP	2.36e-04	772	71	10	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	MAPK8IP1 IGF2BP1 GTF3C1 SEC24B NUMB FGFR2 SON HDLBP	2.52e-04	498	71	8	gudmap_developingGonad_e11.5_testes_k5_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	EGR1 NFIB VCAN SCN2A PSD3 NUMB CACHD1 FGFR2 NR4A1 BGN	3.05e-04	797	71	10	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
ToppCell	normal-na-Myeloid-classical_monocyte-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	EGR1 VCAN CAST AHR IRS2 NUP214 LYST	3.32e-08	198	72	7	58aa5041077fe17ca01c5e6da077d8008d5123ab
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NFIB NR5A2 AHR HID1 NIPBL LDB2 SON	3.56e-08	200	72	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NFIB CACHD1 FGFR2 PAX9 PTPRU ADARB2	4.29e-07	177	72	6	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NFIB CACHD1 FGFR2 PAX9 PTPRU ADARB2	4.29e-07	177	72	6	ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NFIB VCAN NR3C1 ADARB2 LDB2 BGN	5.56e-07	185	72	6	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	(2)_NK/T-(210)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	PWWP2A IGF2BP1 GTF3C1 CAST FGFR2 RUNX3	6.30e-07	189	72	6	fa72e87e1e8cd7cbddae7b47e19cf90d181820a7
ToppCell	(2)_NK/T-(21)_NKT_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	PWWP2A IGF2BP1 GTF3C1 CAST FGFR2 RUNX3	6.30e-07	189	72	6	b37ad24898a14a4a3b2d6cea2637de2471f76e20
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HMBOX1 NFIB NR5A2 CACHD1 LYST LDB2	6.50e-07	190	72	6	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KANK1 PIK3C2G MALL CACHD1 FGFR2 NR4A1	6.70e-07	191	72	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NFIB PRKAA2 NR5A2 HID1 THSD1 LDB2	6.70e-07	191	72	6	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	Control-Epithelial-Club\|Control / Disease state, Lineage and Cell class	MALL NFIB AHR CACHD1 FGFR2 PTPRU	6.90e-07	192	72	6	d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KANK1 NFIB CACHD1 FGFR2 PAX9 PTPRU	6.90e-07	192	72	6	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NR5A2 CACHD1 THSD1 LDB2	7.12e-07	193	72	6	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 KANK1 DNAJA4 NFIB THSD1 BGN	7.12e-07	193	72	6	eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NR5A2 CACHD1 THSD1 LDB2	7.12e-07	193	72	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	facs-Skin-Anagen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPK8IP1 KANK1 DNAJA4 NFIB THSD1 BGN	7.34e-07	194	72	6	5d30d3d41d5f19cdf3077cc609aa2738762cb8c5
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	KANK1 MALL NFIB AHR CACHD1 FGFR2	7.56e-07	195	72	6	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area\|World / Primary Cells by Cluster	NFIB VCAN SCN2A PSD3 PTPRU LDB2	8.02e-07	197	72	6	79b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33\|World / Primary Cells by Cluster	NFIB VCAN SCN2A PSD3 PTPRU LDB2	8.02e-07	197	72	6	d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EGR1 VCAN IRS2 NUP214 F5 LYST	8.02e-07	197	72	6	15bcfe6105c0b508811fb9bba0bc4312fea04f4c
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EGR1 MUC17 VCAN AHR NUMB LYST	8.26e-07	198	72	6	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	EGR1 MUC17 VCAN AHR NUMB LYST	8.26e-07	198	72	6	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	EGR1 VCAN CAST NR4A1 NR3C1 BGN	8.76e-07	200	72	6	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRKAA2 PSD3 IRS2 HID1 PAX9 ADARB2	8.76e-07	200	72	6	ed093626a9cac7531a2bf02f6e345c5e84b8c060
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	EGR1 VCAN CAST NR4A1 NR3C1 BGN	8.76e-07	200	72	6	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	COVID-19_Convalescent-Classical_Monocyte\|COVID-19_Convalescent / Disease condition and Cell class	EGR1 VCAN AHR NUP214	5.71e-06	72	72	4	73db21be480920fc936f3a965495f5cf004e350a
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3\|TCGA-Uterus / Sample_Type by Project: Shred V9	CPEB2 RPS6KA5 AHR FRYL LYST	6.75e-06	163	72	5	d64dd39b077105c73e570ccef70f0e74a2c586ac
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LILRA1 VCAN NUP214 F5 LYST	8.28e-06	170	72	5	46a81d505de845cc59f80594fce338f7fdb9250f
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LILRA1 VCAN NUP214 F5 LYST	8.28e-06	170	72	5	1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LILRA1 VCAN NUP214 F5 LYST	8.28e-06	170	72	5	830646815410c47e9bca8c9bae75dfc45c9c9b33
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122\|Adult / Lineage, Cell type, age group and donor	PRKAA2 NR5A2 HID1 THSD1 LDB2	9.01e-06	173	72	5	dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KANK1 PIK3C2G SCN2A USP43 CACHD1	1.12e-05	181	72	5	e0abf2707d9e0aa942c657eef7d2cbcd02f060dd
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 MALL ZC3H12B FRYL LDB2	1.12e-05	181	72	5	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	NFIB CACHD1 FGFR2 PAX9 PTPRU	1.15e-05	182	72	5	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	NFIB CACHD1 FGFR2 PAX9 PTPRU	1.15e-05	182	72	5	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 KANK1 PIK3C2G SCN2A CACHD1	1.18e-05	183	72	5	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	KANK1 NFIB CACHD1 FGFR2 PTPRU	1.18e-05	183	72	5	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EGR1 VCAN NUMB IRS2 F5	1.28e-05	186	72	5	05c40bac5c0ade8b67b7c2112739466e02dbf22b
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EGR1 VCAN SCN2A AHR IRS2	1.28e-05	186	72	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	MALL NFIB AHR CACHD1 FGFR2	1.28e-05	186	72	5	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	PSD3 CACHD1 FGFR2 PAX9 ADARB2	1.31e-05	187	72	5	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	facs-Heart-RA-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 MALL HID1 FGFR2 PTPRU	1.35e-05	188	72	5	4ddb11a90bf3baa7237bde304db44dfcc56aed52
ToppCell	facs-Heart-RA-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 MALL HID1 FGFR2 PTPRU	1.35e-05	188	72	5	e47e66906922d5c69b1aafe28face0787d3fc563
ToppCell	Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NFIB NR5A2 FRYL THSD1 LDB2	1.35e-05	188	72	5	117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGR1 NFIB AHR NIPBL SON	1.35e-05	188	72	5	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	HOXB3 NFIB VCAN NR3C1 BGN	1.35e-05	188	72	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	KANK1 MALL AHR CACHD1 FGFR2	1.35e-05	188	72	5	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 KANK1 PIK3C2G SCN2A USP43	1.38e-05	189	72	5	977a813e5d7a5a561c1fced2bbf21c20056b88d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HOXB3 KANK1 PIK3C2G SCN2A CACHD1	1.38e-05	189	72	5	975c0f079903ae36b0ffa54e86294d42ec7697de
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HOXB3 KANK1 PIK3C2G SCN2A CACHD1	1.38e-05	189	72	5	7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KANK1 MALL CACHD1 FGFR2 NR4A1	1.42e-05	190	72	5	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	KANK1 CACHD1 FGFR2 PAX9 PTPRU	1.42e-05	190	72	5	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	KANK1 MALL AHR CACHD1 FGFR2	1.42e-05	190	72	5	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LILRA1 VCAN NUP214 F5 LYST	1.45e-05	191	72	5	5d6ef70cc15ec5e983a953e547e40f9c06e355fb
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MALL NFIB NR5A2 BSN LDB2	1.45e-05	191	72	5	dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b
ToppCell	390C-Myeloid-Mast_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	RPS6KA5 EGR1 DNAJA4 AHR NR4A1	1.45e-05	191	72	5	88bcd0b85b2112cef15c9e44d1429f9fba4a3400
ToppCell	390C-Myeloid-Mast_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	RPS6KA5 EGR1 DNAJA4 AHR NR4A1	1.45e-05	191	72	5	c1517ea7b10a7f732725b4c0224fbfecae80d18b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	COL11A2 RPS6KA5 NFIB FGFR2 LDB2	1.49e-05	192	72	5	d0649410cf5eacdb0c1dce70e37c7473ef5fddfa
ToppCell	PND07\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	EGR1 NFIB VCAN NR4A1 BGN	1.49e-05	192	72	5	8171a60df481195c39a7f740effcae8e4deb6ca7
ToppCell	367C-Myeloid-Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 DNAJA4 VCAN IRS2 NR4A1	1.49e-05	192	72	5	26326d7c3d907d754e85e128b7d8a52e90863f3f
ToppCell	COPD-Epithelial-Goblet\|COPD / Disease state, Lineage and Cell class	MALL PRKAA2 FGFR2 PAX9 PTPRU	1.49e-05	192	72	5	93b2ca0a97776d28c7e8f1a0642c4b63a5554aab
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	KANK1 PIK3C2G MALL CACHD1 FGFR2	1.49e-05	192	72	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NR5A2 THSD1 LDB2	1.53e-05	193	72	5	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	10x5'-Lung-Myeloid_Monocytic\|Lung / Manually curated celltypes from each tissue	LILRA1 VCAN NUP214 F5 LYST	1.53e-05	193	72	5	ebe6be10ef5de9e1da988e263106698d3db42fce
ToppCell	droplet-Bladder-nan-3m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGR1 NFIB VCAN NR4A1 BGN	1.53e-05	193	72	5	e55f79bad6888b84b0ad5fccded498b170e3c6dc
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NUMB THSD1 LDB2	1.53e-05	193	72	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NUMB THSD1 LDB2	1.53e-05	193	72	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NR5A2 THSD1 LDB2	1.53e-05	193	72	5	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	367C-Myeloid-Monocyte-CD14+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 DNAJA4 VCAN IRS2 NR4A1	1.53e-05	193	72	5	c7ecd98729419b34c14f9b387b15472c47951d2f
ToppCell	10x5'-GI_small-bowel\|World / Manually curated celltypes from each tissue	EGR1 MUC17 DNAJA4 AHR NR4A1	1.53e-05	193	72	5	cd89dfe53a114078f06343049685883c8e26508f
ToppCell	droplet-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGR1 NFIB PAX9 NR4A1 NIPBL	1.53e-05	193	72	5	07ddb9525b686c31fa7df4286557d1e58f7ead52
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJA4 A4GNT HID1 NR4A1 PRRC1	1.57e-05	194	72	5	0797245ebfa389a6f66874cb0f11297f1456e600
ToppCell	Control-Classical_Monocyte\|Control / Disease condition and Cell class	EGR1 VCAN IRS2 NUP214 F5	1.57e-05	194	72	5	9e33e1b54b4114f9e6981819834bb796ed7192b5
ToppCell	tumor_Lung\|World / Location, Cell class and cell subclass	EGR1 AHR NR4A1 NR3C1 BGN	1.57e-05	194	72	5	7e6b8a30f8d08252ad3f1df826d6f7c0ba997c2c
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	VCAN IRS2 NUP214 F5 LYST	1.57e-05	194	72	5	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	droplet-Bladder-nan-3m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGR1 NFIB VCAN NR4A1 BGN	1.57e-05	194	72	5	b294056f9bdc243263cf36dce7b62564144b9de1
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HMBOX1 NFIB NR5A2 CACHD1 LDB2	1.57e-05	194	72	5	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-secretory_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAJA4 A4GNT HID1 NR4A1 PRRC1	1.57e-05	194	72	5	0241b4b88d6210b4c1b8aa99db17115b18142f01
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VCAN PSD3 ADARB2 LDB2 BGN	1.61e-05	195	72	5	d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d
ToppCell	367C-Myeloid-Monocyte-CD14+_Monocyte\|367C / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 DNAJA4 VCAN IRS2 NUP214	1.61e-05	195	72	5	4f9e26e033353fc9a8bdbd10358ee68ab2291880
ToppCell	distal-Hematologic-Classical_Monocyte-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 VCAN IRS2 NUP214 F5	1.61e-05	195	72	5	32c34741e35006b7238896fd04a497011297dd22
ToppCell	11.5-Distal-Endothelial\|Distal / Age, Tissue, Lineage and Cell class	NR5A2 AHR HID1 THSD1 LDB2	1.61e-05	195	72	5	efdede0f476883ffddd247fa7bc6449e7932613e
ToppCell	11.5-Distal-Endothelial-Endothelial\|Distal / Age, Tissue, Lineage and Cell class	NR5A2 AHR HID1 THSD1 LDB2	1.61e-05	195	72	5	1e9b52b201ab6c78f536609e2afe1d680c71a6e7
ToppCell	metastatic_Brain-Myeloid_cells-Microglia/Mac\|Myeloid_cells / Location, Cell class and cell subclass	EGR1 MALL NFIB PAX9 NR4A1	1.61e-05	195	72	5	98a21f5e27d98384b3086034bd6f83441e2e4ef9
ToppCell	severe-Classical_Monocyte\|World / disease stage, cell group and cell class	EGR1 VCAN AHR IRS2 NUP214	1.61e-05	195	72	5	cf638aac4d57ae0774008920a1a5e9dfd8c73885
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Monocytes\|Myeloid_cells / Location, Cell class and cell subclass	LILRA1 VCAN IRS2 NUP214 LYST	1.61e-05	195	72	5	8861c82129f3ef241b1e9fa4825e4621550cee96
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CPEB2 KANK1 PIK3C2G SCN2A CACHD1	1.61e-05	195	72	5	a38d9dc6192aea673d96fda6b25e81223fda3abf
ToppCell	P03-Mesenchymal\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EGR1 NFIB VCAN NR4A1 BGN	1.61e-05	195	72	5	6180309c6ae278b996fd98c57461cbc129c028ba
ToppCell	343B-Myeloid-Monocyte-CD14+_Monocyte\|343B / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 VCAN NUP214 NR4A1 F5	1.61e-05	195	72	5	b5ee368c97113432fc8fe742654cd538558f327c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VCAN PSD3 ADARB2 LDB2 BGN	1.65e-05	196	72	5	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EGR1 VCAN AHR IRS2 LYST	1.65e-05	196	72	5	1d170422a9eb5e477ce837f9da1c7db95ee5da1c
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 NFIB ZNF185 NR3C1 THSD1	1.65e-05	196	72	5	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	VCAN IRS2 NUP214 F5 LYST	1.65e-05	196	72	5	ad193b231ff2f7c72590fab79919c179d5d2f327
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HOXB3 EGR1 NFIB VCAN BGN	1.65e-05	196	72	5	028a06ed92f1c058dcbeacd335625bf529e87a7b
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KANK1 NFIB ZNF185 NR3C1 THSD1	1.65e-05	196	72	5	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	367C-Myeloid-Monocyte\|367C / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 DNAJA4 VCAN IRS2 NUP214	1.65e-05	196	72	5	202066aeb837659fcc2e127fb52d7189e2e3520d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VCAN PSD3 ADARB2 LDB2 BGN	1.65e-05	196	72	5	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	severe_COVID-19-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	EGR1 VCAN IRS2 NUP214 F5	1.69e-05	197	72	5	cdffd49db7374d223ded46d636cd4be12d464ea4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	VCAN PSD3 ADARB2 LDB2 BGN	1.69e-05	197	72	5	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	EGR1 PIK3C2G MALL CACHD1 NR4A1	1.69e-05	197	72	5	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
Drug	Ursolic acid [77-52-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	EGR1 MALL FUBP1 PSD3 IRS2 NR4A1 LYST	1.94e-06	182	73	7	2230_UP
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 IRS2 FGFR2 NR4A1 NR3C1 THSD1	2.58e-06	190	73	7	1483_UP
Drug	Hexestrol [84-16-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	EGR1 INSL4 NR5A2 NUP214 NR4A1 NR3C1 BGN	2.67e-06	191	73	7	6077_UP
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	MALL NFIB INSL4 PSD3 NUP214 NR4A1 LYST	2.96e-06	194	73	7	2223_UP
Drug	Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 DNAJA4 FGFR2 NIPBL NUP153 HDLBP	3.17e-06	196	73	7	1543_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	IL12RB1 DVL2 PSD3 IRS2 FGFR2 PTPRU AHDC1	3.39e-06	198	73	7	2771_DN
Drug	Ketoprofen [22071-15-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A	EGR1 MALL PSD3 A4GNT PAX9 THSD1 BSN	3.39e-06	198	73	7	2316_UP
Drug	Phenytoin	EGR1 VCAN SCN2A AHR PAX3 FGFR2 NR3C1 NUP153 LDB2	3.85e-06	385	73	9	ctd:D010672
Drug	heparin-sepharose	AHR NR3C1	1.01e-05	2	73	2	ctd:C037405
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	EGR1 DVL2 AHR IRS2 NR4A1 THSD1	1.10e-05	156	73	6	1010_UP
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	EGR1 NFIB IRS2 HUWE1 NR4A1 NR3C1	1.56e-05	166	73	6	3283_UP
Drug	Perhexiline maleate [6724-53-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 IRS2 NR4A1 NR3C1 ARHGEF11	1.78e-05	170	73	6	5501_UP
Drug	wortmannin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	RPS6KA5 EGR1 FRYL IRS2 THSD1 MXI1	2.04e-05	174	73	6	977_UP
Drug	wortmannin; Up 200; 1uM; MCF7; HT_HG-U133A_EA	RPS6KA5 EGR1 FRYL IRS2 THSD1 MXI1	2.10e-05	175	73	6	869_UP
Drug	Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A	EGR1 DVL2 IRS2 NUP214 NR4A1 BGN	2.10e-05	175	73	6	3295_UP
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A	EGR1 MALL IRS2 NR4A1 F5 BGN	2.24e-05	177	73	6	4164_UP
Drug	AC1L1D59	PIKFYVE RPS6KA5 EGR1 PIK3C2G AHR IRS2 NR4A1	2.32e-05	266	73	7	CID000002199
Drug	trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 AHR THSD1 LYST MXI1	2.46e-05	180	73	6	6579_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 NFIB IRS2 NR3C1 MXI1	2.88e-05	185	73	6	6945_UP
Drug	Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A	PSD3 IRS2 FGFR2 NR4A1 NR3C1 AHDC1	2.88e-05	185	73	6	7055_UP
Drug	Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	EGR1 DNAJA4 MALL IRS2 PTPRU ARHGEF11	3.15e-05	188	73	6	3281_UP
Drug	Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A	EGR1 MALL NR5A2 A4GNT IRS2 F5	3.24e-05	189	73	6	2300_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 PTPRU MAPKBP1 THSD1 AHDC1	3.24e-05	189	73	6	5578_DN
Drug	geldanamycin; Up 200; 1uM; MCF7; HG-U133A	INSL4 FGFR2 NR4A1 NR3C1 NIPBL HDLBP	3.24e-05	189	73	6	611_UP
Drug	trichostatin A; Up 200; 0.1uM; MCF7; HG-U133A	RPS6KA5 AHR NR4A1 F5 TREML2 MXI1	3.34e-05	190	73	6	331_UP
Drug	Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	EGR1 MALL NFIB IRS2 NR4A1 BGN	3.34e-05	190	73	6	6825_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; HL60; HT_HG-U133A	EGR1 VCAN AHR NR4A1 NIPBL HDLBP	3.34e-05	190	73	6	1342_UP
Drug	Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A	EGR1 MALL NR5A2 PSD3 IRS2 NR4A1	3.44e-05	191	73	6	4791_UP
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A	EGR1 NUP214 FGFR2 NR3C1 RUNX3 BGN	3.54e-05	192	73	6	5216_UP
Drug	estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	NFIB DVL2 FGFR2 NR4A1 NR3C1 ARHGEF11	3.54e-05	192	73	6	5955_UP
Drug	reverse T	MAPK8IP1 AHR F5 BGN	3.62e-05	58	73	4	CID000064973
Drug	MEK1/2 inhibitor	PIKFYVE RPS6KA5 EGR1 PIK3C2G AHR NR4A1	3.65e-05	193	73	6	CID009549284
Drug	Amoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A	EGR1 NR5A2 IRS2 MAPKBP1 THSD1 BGN	3.65e-05	193	73	6	4996_UP
Drug	Antazoline hydrochloride [2508-72-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	SCN2A INSL4 PSD3 ARHGEF11 F5 LDB2	3.75e-05	194	73	6	3173_UP
Drug	17-AAG; Down 200; 1uM; SKMEL5; HG-U133A	EGR1 PAX3 NR4A1 NR3C1 RUNX3 NIPBL	3.86e-05	195	73	6	505_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; HL60; HT_HG-U133A	DNAJA4 DVL2 NR4A1 ARHGEF11 F5 AHDC1	3.86e-05	195	73	6	2409_DN
Drug	Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; HL60; HG-U133A	RPS6KA5 CAST NR4A1 NR3C1 PTPRU PRRC1	3.86e-05	195	73	6	1573_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; MCF7; HT_HG-U133A	FUBP1 NR5A2 PSD3 FGFR2 HUWE1 PAX9	3.97e-05	196	73	6	5989_UP
Drug	Methylprednisolone, 6-alpha [83-43-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	DVL2 PSD3 A4GNT IRS2 PTPRU MAPKBP1	3.97e-05	196	73	6	6785_UP
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	HOXB3 DNAJA4 HUWE1 NR3C1 ARHGEF11 LDB2	4.09e-05	197	73	6	6412_DN
Drug	Gibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	EGR1 NFIB VCAN INSL4 NR4A1 NR3C1	4.09e-05	197	73	6	4818_UP
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A	HOXB3 IRS2 PAX3 PAX9 MAPKBP1 LYST	4.09e-05	197	73	6	3617_UP
Drug	Ethisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A	IL12RB1 EGR1 VCAN NR5A2 DVL2 FGFR2	4.09e-05	197	73	6	2366_UP
Drug	Corynanthine hydrochloride [66634-44-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	EGR1 DNAJA4 NR4A1 NR3C1 BGN HDLBP	4.09e-05	197	73	6	2786_UP
Drug	Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A	DNAJA4 MALL VCAN FGFR2 NR3C1 F5	4.09e-05	197	73	6	3365_UP
Drug	Azaperone [1649-18-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	HOXB3 DNAJA4 NFIB NR4A1 RUNX3 LYST	4.09e-05	197	73	6	3573_UP
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	EGR1 NUMB NR4A1 MAPKBP1 NIPBL AHDC1	4.21e-05	198	73	6	7180_DN
Drug	butein; Down 200; 10uM; MCF7; HG-U133A	IL12RB1 MALL NFIB INSL4 NUP214 FGFR2	4.21e-05	198	73	6	607_DN
Drug	Urosiol [128-13-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A	HOXB3 DNAJA4 PSD3 NUP214 RUNX3 BGN	4.21e-05	198	73	6	6484_UP
Drug	Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A	VCAN PSD3 IRS2 RUNX3 F5 BGN	4.33e-05	199	73	6	5544_UP
Drug	Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; HL60; HG-U133A	GTF3C1 VCAN CAST A4GNT NR4A1 MAPKBP1	4.33e-05	199	73	6	1442_UP
Drug	Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A	DNAJA4 MALL PRKAA2 IRS2 NUP214 ARHGEF11	4.45e-05	200	73	6	1474_UP
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A	RPS6KA5 INSL4 IRS2 NUP214 PTPRU MAPKBP1	4.45e-05	200	73	6	2632_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A	HOXB3 EGR1 CAST THSD1 LYST BGN	4.45e-05	200	73	6	5521_UP
Drug	fluocinolone	MAPK8IP1 NR3C1	6.06e-05	4	73	2	CID000091488
Drug	4,7-phenanthroline	AHR NR3C1	6.06e-05	4	73	2	CID000067472
Drug	4-S-UTP	ERVK-6 GTF3C1	6.06e-05	4	73	2	CID003033941
Drug	SL 327	RPS6KA5 EGR1 AHR	6.91e-05	25	73	3	ctd:C424127
Drug	3-O-methyl-D-glucose	PIKFYVE PIK3C2G IRS2 ADARB2	8.48e-05	72	73	4	CID000008973
Drug	AC1L9K70	EGR1 HGS NR5A2 NR3C1 NIPBL AHDC1	9.18e-05	228	73	6	CID000446871
Drug	aurin	EGR1 AHR NR3C1	9.78e-05	28	73	3	ctd:C017037
Drug	HCDF	AHR NR3C1	1.01e-04	5	73	2	CID000051130
Drug	fipexide	HGS F5	1.01e-04	5	73	2	CID000003351
Drug	GF109203X	PIKFYVE RPS6KA5 EGR1 PIK3C2G NUP214 NR4A1 NR3C1	1.11e-04	341	73	7	CID000002396
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	EGR1 AHR IRS2 FGFR2 NR4A1	1.42e-04	155	73	5	1068_UP
Drug	Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A	EGR1 VCAN PSD3 IRS2 NR4A1	1.51e-04	157	73	5	2651_UP
Drug	1,2,3,4,7,8-hexachlorodibenzofuran	AHR NR3C1	1.51e-04	6	73	2	ctd:C051412
Drug	2,6-di-tert-butyl-4-hydroxy-4-methyl-2,5-cyclohexadien-1-one	AHR NR3C1	1.51e-04	6	73	2	ctd:C038639
Drug	18-VP	NR4A1 NR3C1	1.51e-04	6	73	2	CID000133557
Drug	18EP	NR4A1 NR3C1	1.51e-04	6	73	2	CID003082761
Drug	SP600125	PIKFYVE MAPK8IP1 RPS6KA5 EGR1 PIK3C2G AHR FGFR2	1.60e-04	362	73	7	CID000008515
Drug	AC1L1AWH	EGR1 HGS LYST	1.61e-04	33	73	3	CID000001178
Drug	Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; MCF7; HT_HG-U133A	EGR1 AHR IRS2 FGFR2 NR3C1	1.69e-04	161	73	5	5439_UP
Drug	ON 01910	EGR1 NFIB FGFR2 NR3C1 MXI1	1.74e-04	162	73	5	ctd:C507134
Drug	Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 IRS2 NR4A1 MAPKBP1	1.74e-04	162	73	5	1486_UP
Drug	thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	EGR1 IRS2 NR4A1 NR3C1 LYST	1.74e-04	162	73	5	1655_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	EGR1 IRS2 NR4A1 NR3C1 SON	1.85e-04	164	73	5	3852_UP
Drug	Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; MCF7; HT_HG-U133A	EGR1 PSD3 AHR IRS2 NR3C1	1.95e-04	166	73	5	3518_UP
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	EGR1 VCAN IRS2 NR4A1 NR3C1	2.01e-04	167	73	5	6047_UP
Drug	Sistan	ERVK-6 VCAN ZNF185	2.09e-04	36	73	3	CID003001858
Drug	drotaverine HCl	NUMB NR3C1	2.11e-04	7	73	2	CID000026394
Drug	Tolterodine Tartrate	AHR NR3C1	2.11e-04	7	73	2	ctd:D000068737
Drug	MT-19	EGR1 NR4A1	2.11e-04	7	73	2	CID003083507
Drug	celastrol; Up 200; 2.5uM; MCF7; HT_HG-U133A_EA	EGR1 DNAJA4 IRS2 NR4A1 NR3C1	2.24e-04	171	73	5	887_UP
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A	EGR1 DNAJA4 INSL4 IRS2 NR3C1	2.24e-04	171	73	5	3297_UP
Drug	Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 THSD1 LYST MXI1	2.37e-04	173	73	5	1659_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	RPS6KA5 IRS2 THSD1 LYST MXI1	2.37e-04	173	73	5	5308_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA	RPS6KA5 EGR1 IRS2 THSD1 MXI1	2.37e-04	173	73	5	1016_UP
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A	EGR1 MALL IRS2 NR3C1 THSD1	2.37e-04	173	73	5	6451_UP
Drug	Thonzonium bromide [553-08-2]; Up 200; 6.8uM; PC3; HT_HG-U133A	EGR1 IRS2 NR4A1 NR3C1 BGN	2.37e-04	173	73	5	4617_UP
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	HMBOX1 NFIB NUMB FRYL NIPBL	2.43e-04	174	73	5	7530_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA	RPS6KA5 EGR1 IRS2 LYST MXI1	2.43e-04	174	73	5	1019_UP
Drug	2,6-dihydroxybenzoic acid	EGR1 NFIB HGS NR4A1 NR3C1	2.49e-04	175	73	5	CID000009338
Drug	IL-1R antagonist	HUWE1 LYST BGN MXI1	2.59e-04	96	73	4	CID010447660
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	AHR IRS2 FGFR2 THSD1 LYST	2.63e-04	177	73	5	5745_UP
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	RPS6KA5 EGR1 THSD1 LYST MXI1	2.63e-04	177	73	5	4821_UP
Drug	beta-hydroxyasparagine	SCN2A AHR F5	2.66e-04	39	73	3	CID000152191
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	HOXB3 IRS2 FGFR2 NR4A1 THSD1	2.70e-04	178	73	5	4483_UP
Drug	1,7-phenanthroline	AHR NR3C1	2.80e-04	8	73	2	ctd:C053486
Drug	C05475	HGS NR3C1	2.80e-04	8	73	2	CID000440696
Disease	Insulin Resistance	PRKAA2 AHR IRS2 NR4A1	1.36e-05	60	71	4	C0021655
Disease	Insulin Sensitivity	PRKAA2 AHR IRS2 NR4A1	1.36e-05	60	71	4	C0920563
Disease	prostate cancer (implicated_via_orthology)	PAX3 FGFR2 HDLBP	6.92e-05	33	71	3	DOID:10283 (implicated_via_orthology)
Disease	C-reactive protein measurement	IL12RB1 IGF2BP1 NFIB CAST PSD3 NUMB IRS2 CACHD1 HID1 BSN HDLBP	1.37e-04	1206	71	11	EFO_0004458
Disease	1-methylxanthine measurement	PSD3 AHR	3.10e-04	11	71	2	EFO_0021174
Disease	Spina Bifida	PAX3 FGFR2	3.71e-04	12	71	2	C0080178
Disease	Status Dysraphicus	PAX3 FGFR2	3.71e-04	12	71	2	C0038219
Disease	Rachischisis	PAX3 FGFR2	3.71e-04	12	71	2	C0266508
Disease	adverse effect, response to xenobiotic stimulus	NFIB RUNX3 ADARB2	3.94e-04	59	71	3	EFO_0009658, GO_0009410
Disease	Brain Ischemia	IL12RB1 EGR1 F5	4.14e-04	60	71	3	C0007786
Disease	Cerebral Ischemia	IL12RB1 EGR1 F5	4.14e-04	60	71	3	C0917798
Disease	cystatin C measurement	IGF2BP1 NFIB AHR BSN RUNX3 ADARB2	4.18e-04	402	71	6	EFO_0004617
Disease	ovary epithelial cancer (is_marker_for)	FUBP1 RUNX3	4.38e-04	13	71	2	DOID:2152 (is_marker_for)
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	PIKFYVE F5	4.38e-04	13	71	2	EFO_0802114
Disease	Craniofacial Abnormalities	COL11A2 PAX3 FGFR2 NIPBL	5.55e-04	156	71	4	C0376634
Disease	platelet storage pool deficiency (implicated_via_orthology)	HPS5 LYST	5.87e-04	15	71	2	DOID:2223 (implicated_via_orthology)
Disease	Limb Deformities, Congenital	COL11A2 FGFR2	7.58e-04	17	71	2	C0206762
Disease	type 2 diabetes mellitus (is_implicated_in)	MAPK8IP1 PIK3C2G PRKAA2 IRS2	7.82e-04	171	71	4	DOID:9352 (is_implicated_in)
Disease	Febrile seizure (within the age range of 3 months to 6 years)	SCN2A BSN	8.52e-04	18	71	2	HP_0002373
Disease	squamous cell carcinoma (is_marker_for)	EGR1 FGFR2	9.51e-04	19	71	2	DOID:1749 (is_marker_for)
Disease	longitudinal BMI measurement	PIK3C2G CAST PSD3	1.03e-03	82	71	3	EFO_0005937
Disease	number of teeth measurement	IGF2BP1 PAX9	1.05e-03	20	71	2	EFO_0010073
Disease	portal hypertension (biomarker_via_orthology)	FGFR2 F5	1.28e-03	22	71	2	DOID:10762 (biomarker_via_orthology)
Disease	femoral neck bone mineral density	KANK1 RPS6KA5 NFIB FUBP3	1.30e-03	196	71	4	EFO_0007785
Disease	Dyslipidemias	NR5A2 AHR	1.52e-03	24	71	2	C0242339
Disease	Dyslipoproteinemias	NR5A2 AHR	1.52e-03	24	71	2	C0598784
Disease	Impaired glucose tolerance	PRKAA2 NR5A2	1.65e-03	25	71	2	C0271650
Disease	primary biliary cholangitis (is_marker_for)	IL12RB1 NR3C1	1.65e-03	25	71	2	DOID:12236 (is_marker_for)
Disease	migraine disorder	HOXB3 KANK1 NFIB NR3C1 ADARB2	1.71e-03	357	71	5	MONDO_0005277
Disease	Adenoid Cystic Carcinoma	NFIB VCAN SON	1.83e-03	100	71	3	C0010606
Disease	Pancreatic Neoplasm	NR5A2 AHR NR4A1	1.83e-03	100	71	3	C0030297
Disease	Malignant neoplasm of pancreas	NR5A2 AHR NR4A1	1.93e-03	102	71	3	C0346647
Disease	Liver Cirrhosis	AHR FGFR2 F5	1.99e-03	103	71	3	C0023890
Disease	TYPE 2 DIABETES MELLITUS	MAPK8IP1 IRS2	2.07e-03	28	71	2	125853
Disease	Type 2 diabetes mellitus	MAPK8IP1 IRS2	2.07e-03	28	71	2	cv:C0011860
Disease	Fibrosis, Liver	AHR FGFR2 F5	2.10e-03	105	71	3	C0239946
Disease	glucose measurement	MAPK8IP1 PIK3C2G CAST PSD3 BSN	2.24e-03	380	71	5	EFO_0004468

Protein segments in the cluster

Peptide	Gene	Start	Entry
MGSFEPSPYPTTSSL	AHR	721	P35869
FSTMPTLPPSYNTSE	VCAN	46	P13611
PDVMEGSNPPYYTDT	VCAN	2796	P13611
YLASSPPSGSFMDDS	PRKAA2	341	P54646
TDSTPMPSNSTYPAF	A4GNT	91	Q9UNA3
FYVSMPSGPPDSSTD	ARHGEF11	1361	O15085
GYSTMSPQEDSENPP	CACHD1	1196	Q5VU97
GSGSPSFSSPMDIFD	DNAJA4	76	Q8WW22
PYSMNPSTPSDGTFG	AHDC1	1346	Q5TGY3
LTGTFPAYPGSSSMS	DVL2	386	O14641
MEPSPTGDFYPSPSS	NFIB	281	O00712
TPSPGDTPSMYCEAK	ADARB2	686	Q9NS39
PPTNSSFSSDFMPKE	PIK3C2G	176	O75747
GESYSMPTAFPGLAP	NR4A1	221	P22736
SSGDDSVFSPDPMPY	FGFR2	791	P21802
GSFVSASSMAPYPTP	PAX9	266	P55771
MASPDPPATSYAPSD	MALL	1	Q13021
MADYSTVPPPSSGSA	FUBP1	1	Q96AE4
RMSVSSDPDPAAYPS	MAPK8IP1	306	Q9UQF2
PPSSVTGAAPYSSFM	IGF2BP1	386	Q9NZI8
DAPPSTSTMDDEGYP	HPS5	931	Q9UPZ3
AYATTAPMTPESSGP	KIAA1614	746	Q5VZ46
MSSTPHDPFYSSPFG	LDB2	1	O43679
PTFMSLYSPTETPSG	BSN	1156	Q9UPA5
SPVVPMSSAPSETSY	BSN	3166	Q9UPA5
MSSAPSETSYSGPAV	BSN	3171	Q9UPA5
ISDPFGSFPHSPTMD	EGR1	16	P18146
GMSPSPSNSYDTSPQ	HMBOX1	96	Q6NT76
SELSYAPMTPDHFPS	PDPR	636	Q8NCN5
DPDSVTPTYSAMCPF	BGN	51	P21810
SMTFGSPEFSSPEDT	FAM214A	426	Q32MH5
DFIPDYQPSPMTDSG	FRYL	1696	O94915
ASAAPQASSPPDYTM	FUBP3	531	Q96I24
PSDSDMEDYSPPPSL	NIPBL	1151	Q6KC79
EPPYYDVMTTGTTPD	COL11A2	276	P13942
TGTPPFMASPLSEMY	PLK5	6	Q496M5
DYGSYAPAAPTTSSM	KANK1	221	Q14678
NPATPSTAMGSSVPY	NUP214	1131	P35658
NGYSSPSMRPDVSSP	NR3C1	391	P04150
EFTEMDPTYSPAALP	RPS6KA5	351	O75582
SYCPMPEKTFTTTPG	INSL4	41	Q14641
DGTPMPDSYPTTPSS	HUWE1	2736	Q7Z6Z7
NISAPSFDYADMPSP	PTPRU	586	Q92729
YTDSFVPPSGPSNPM	PAX3	366	P23760
SPSDPGFMSLDEYGS	IRS2	491	Q9Y4H2
SGSPMVPSYETSVSP	PIKFYVE	316	Q9Y2I7
PDSENGFYPGLPSSM	CPEB2	6	Q7Z5Q1
SMTPSYESPSPPAFG	HOXB3	281	P14651
TYTGPEVSDPMSSTY	CAST	176	P20810
MVISPSGFTASPYEG	LYST	2071	Q99698
TAPQDPDPAGMATYS	IL12RB1	386	P42701
YPEPSDNPTMDTSEF	MAPKBP1	956	O60336
GGSYPDMLSSSASSP	SEC24B	411	O95487
SPTPAEGTSMPTSTY	MUC17	846	Q685J3
SPTPAEGTSMPTSTY	MUC17	1671	Q685J3
SPTTADGTSMPTPAY	MUC17	1966	Q685J3
PTPAYSEGSTPLTSM	MUC17	1976	Q685J3
SPTPAEGTSMPISTY	MUC17	3086	Q685J3
TSTPSEGSTPLTYMP	MUC17	3156	Q685J3
SPPIADGTSMPTSTY	MUC17	3321	Q685J3
NAFSTPEDPFSSAPM	NUMB	336	P49757
SEYPDPYTSSPESIM	NR5A2	271	O00482
PGAMSAAFPYSATPS	RUNX3	271	Q13761
SESFDFPPGSMHAPS	PWWP2A	601	Q96N64
SYSMCSDPSTRDPPG	TREML2	296	Q5T2D2
SFPYPDLGQMPSPSS	F5	1481	P12259
EFPMSPVTSAHSGTY	LILRA1	381	O75019
SEAMYLPPAPESGST	HID1	216	Q8IV36
SSMESFPPLAYSTPQ	PRRC1	46	Q96M27
SPPSPYMGFSGNSKD	USP43	966	Q70EL4
EFTFPMPYTSSMPTA	PRR19	236	A6NJB7
FTMTPEATDNSTPFP	THSD1	101	Q9NS62
AGPYPSMPSTAADPS	HGS	616	O14964
EKTDMTPSTTSPPSY	SCN2A	1961	Q99250
GAEITMPAPSYSPTS	ERVK-6	101	Q9Y6I0
SPSSTGSPMFKFSSP	NUP153	516	P49790
PSTGTRSSCPADYPM	ZC3H12B	666	Q5HYM0
APDMSSSEEFPSFGA	HDLBP	1241	Q00341
VPSSLDESPMAFYEP	GTF3C1	2071	Q12789
SEPDSYFSFEMPLTP	PSD3	466	Q9NYI0
PPRPSSSGYKMTTED	ZNF185	126	O15231
VYPEPSTSTTMDFPE	SON	316	P18583
CEHGYASSFPSMPSP	MXI1	26	P50539